Parkwood »

Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Parkwood

Quarter-by-quarter ownership of Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Parkwood from 13F filings

Historical chart of Parkwood investment in Karyopharm Therapeutics Inc note 3.000%10/1

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics Inc note 3.000%10/1 held by Parkwood consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics Inc note 3.000%10/1 by Parkwood

Quarter filed Position value Share count Share price at filing
2023-03-31 $771k 1.0M 0.77

More positions owned by Parkwood

Vanguard Total Stock Mkt Etf Etp (VTI)
Vanguard Ftse Emerging Marke Etp (VWO)
Ss Spdr S&p Biotech Etf Etp Call Option (XBI)
Axon Enterprise Common Stock (AXON)
Meta Platforms Inc-class A Common Stock (META)
Ishares 20 Year Treasury Bd Etp Call Option (TLT)
Advance Auto Parts Common Stock (AAP)
Amazon.com Common Stock (AMZN)
Td Synnex Corp Common Stock (SNX)
Alphabet Inc-cl C Common Stock (GOOG)
Canadian Natural Resources Common Stock (CNQ)
Ishares Bitcoin Trust Etf Etp (IBIT)
Cloudflare Inc - Class A Common Stock (NET)
Shopify Inc - Class A Common Stock (SHOP)
Elevance Health Common Stock (ELV)

View all positions for Parkwood

Top funds holding Karyopharm Therapeutics Inc note 3.000%10/1

Affinity Asset Advisors
Opaleye Management
Exome Asset Management
Jpmorgan Chase & Co

View all funds holding Karyopharm Therapeutics Inc note 3.000%10/1